Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $2,713 - $3,940
-20 Reduced 0.86%
2,303 $354,000
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $23,676 - $42,008
-200 Reduced 7.93%
2,323 $417,000
Q3 2022

Nov 16, 2022

SELL
$118.07 - $194.18 $944 - $1,553
-8 Reduced 0.32%
2,523 $298,000
Q2 2022

Aug 16, 2022

BUY
$117.13 - $176.59 $3,865 - $5,827
33 Added 1.32%
2,531 $362,000
Q1 2022

May 24, 2022

BUY
$126.46 - $235.05 $315,897 - $587,154
2,498 New
2,498 $430,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track M Holdings Securities, Inc. Portfolio

Follow M Holdings Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.